BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10955800)

  • 1. Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma.
    Lai S; Goepfert H; Gillenwater AM; Luna MA; El-Naggar AK
    Clin Cancer Res; 2000 Aug; 6(8):3172-6. PubMed ID: 10955800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5.
    Kondo M; Matsuoka S; Uchida K; Osada H; Nagatake M; Takagi K; Harper JW; Takahashi T; Elledge SJ; Takahashi T
    Oncogene; 1996 Mar; 12(6):1365-8. PubMed ID: 8649840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.
    Overall ML; Spencer J; Bakker M; Dziadek M; Smith PJ
    Genes Chromosomes Cancer; 1996 Sep; 17(1):56-9. PubMed ID: 8889507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors.
    Orlow I; Iavarone A; Crider-Miller SJ; Bonilla F; Latres E; Lee MH; Gerald WL; Massagué J; Weissman BE; Cordón-Cardó C
    Cancer Res; 1996 Mar; 56(6):1219-21. PubMed ID: 8640801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse.
    Hatada I; Mukai T
    Nat Genet; 1995 Oct; 11(2):204-6. PubMed ID: 7550351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour.
    Taniguchi T; Okamoto K; Reeve AE
    Oncogene; 1997 Mar; 14(10):1201-6. PubMed ID: 9121769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
    Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
    Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
    Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
    Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
    Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu X; An Q; Zhang J; Tang P; Cheng S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome.
    Hatada I; Ohashi H; Fukushima Y; Kaneko Y; Inoue M; Komoto Y; Okada A; Ohishi S; Nabetani A; Morisaki H; Nakayama M; Niikawa N; Mukai T
    Nat Genet; 1996 Oct; 14(2):171-3. PubMed ID: 8841187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.
    Hartmann W; Waha A; Koch A; Goodyer CG; Albrecht S; von Schweinitz D; Pietsch T
    Am J Pathol; 2000 Oct; 157(4):1393-403. PubMed ID: 11021841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.
    Gunduz M; Ouchida M; Fukushima K; Hanafusa H; Etani T; Nishioka S; Nishizaki K; Shimizu K
    Cancer Res; 2000 Jun; 60(12):3143-6. PubMed ID: 10866301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15.
    Matsuoka S; Thompson JS; Edwards MC; Bartletta JM; Grundy P; Kalikin LM; Harper JW; Elledge SJ; Feinberg AP
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3026-30. PubMed ID: 8610162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative reverse transcription-polymerase chain reaction and in situ hybridization analyses of human imprinted p57KIP2 and insulin-like growth factor 2 gene transcripts in fetal kidney and Wilms' tumors using archival tissue.
    Soejima H; McLay J; Hatada I; Mukai T; Jinno Y; Niikawa N; Yun K
    Lab Invest; 1998 Jan; 78(1):19-28. PubMed ID: 9461119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas.
    Kobatake T; Yano M; Toyooka S; Tsukuda K; Dote H; Kikuchi T; Toyota M; Ouchida M; Aoe M; Date H; Pass HI; Doihara H; Shimizu N
    Oncol Rep; 2004 Nov; 12(5):1087-92. PubMed ID: 15492797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic loss and replication errors at microsatellite loci on chromosome 11p in head and neck squamous carcinoma: association with aggressive biological features.
    El-Naggar AK; Hurr K; Huff V; Luna MA; Goepfert H; Batsakis JG
    Clin Cancer Res; 1996 May; 2(5):903-7. PubMed ID: 9816248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16INK4a.
    Waber P; Dlugosz S; Cheng QC; Truelson J; Nisen PD
    Oncogene; 1997 Oct; 15(14):1699-704. PubMed ID: 9349503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.